Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine in Radical Resection of Colorectal Tumors
NCT05484687Completed
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Mar 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of Lidocaine Hydrochloride Injection, without epinephrine in colorectal cancer (CRC), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: Concentration of tumor micrometastasis markers at 3 days. Started Mar 2020; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05484687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05484687.